Aspirin resistance

JK Science

Volumn 8, Issue 2, 2006, Pages 116-117

  Kour, D ^a   Tandon, Vishal R ^a   Kapoor, B ^a   Mahajan, Annil ^a   Parihar, A ^a   Smotra, S ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBOXANE; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG DOSE REGIMEN; DRUG POTENTIATION; DRUG TREATMENT FAILURE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; INCIDENCE; LIFESPAN; META ANALYSIS; PATIENT COMPLIANCE; PROTEIN SYNTHESIS; STROKE; SYSTEMATIC REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

EID: 33746780009     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase. Proc Natl Acad Sci U S A 1975; 72.: 3073-76.
2. Sanmuganathan PS, Ghahramani P, Jackson PR, et al. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta analysis of randomized trials. Heart 2001; 85: 265-67.
3. Hankey GH, Eikeboom JW. Aspirin resistance. BMJ 2004; 328: 477-79.
4. Macchi L, Sorel N, Christiaens L. Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance. Curr Pharm Des 2006; 12: 251-58.
5. Weber AA, Przytulski B, Schanz A, Hohefeld T, Schror K. Towards a defination of aspirin resistance: a typological approach. Platelets 2002; 13: 37-40.
6. FitzGerald GA. Parsing an enigma: the pharmacodynamics of aspirin resistance. Lancet 2003; 361: 542-44.
7. Schafer AI. Genetic and Acquired Determinants of Individual Variability of Response to Antiplatelet Drugs. Circulation 2003; 108: 910-11.
8. Schror K, Weber AA, Hohlfeld T. Aspirin "resistance". Blood Cells Mol Dis 2006; 7: 12-15.
9. Marco Cattaneo. Aspirin and clopidogrel resistance: clinical issues. Arterio throm Vas Biol 2004; 24: 1980-84.
10. Eikelboom JW, Hirsh J, Weitz J et al. Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. 2002; 105: 1650-55.
11. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-17.
12. Cotter G, Shemesh E, Zehavi M et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J 2004; 147: 293-300.